RET and medullary thyroid gland carcinoma: Regarding the potential driver role of RET aneuploidy, particularly gene amplification, since the prevalence of RET amplified and deleted cases is higher in the group of RET positive tumors, we can define that RET gene CNV could not be considered as an alternative mechanism of RET activation but rather it could play a potentiating role in the progression of MTC.